Kasipong, Baby Boy .
HRN: 22-94-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/01/2023
05/07/2023
IV
45mg
Q24hr
Potentially Septic Newborn
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes